Casnate con Bernate, Italy

Carmine Panuccio


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Casnate con Bernat, IT (2013)
  • Casnate con Bernate, IT (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carmine Panuccio

Introduction

Carmine Panuccio is a notable inventor based in Casnate con Bernate, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations for medical use. With a total of 2 patents, his work has the potential to impact the treatment of patients undergoing chemotherapy and radiotherapy.

Latest Patents

Carmine's latest patents focus on shelf-stable liquid formulations of palonosetron. These formulations are designed to reduce chemotherapy and radiotherapy-induced emesis. The innovative aspect of his work lies in the preparation of intravenous and oral liquid medicaments, which can enhance patient comfort and treatment efficacy.

Career Highlights

Throughout his career, Carmine has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Helsinn Healthcare SA and Roche Palo Alto LLC. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.

Collaborations

Carmine has collaborated with several professionals in his field, including Giorgio Calderari and Daniele Bonadeo. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Carmine Panuccio's contributions to the field of pharmaceuticals, particularly through his patents on palonosetron formulations, demonstrate his commitment to improving patient care. His work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…